Skip to content

Goodwill at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$11.39B+5.6%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$48.48B+0.8%
Merck & Co. logo
Merck & Co.MRK
$21.58B-0.5%
Insmed logo
InsmedINSM
$136.11M0.0%
LQD
Liquidia CorporationLQDA
$3.9M0.0%
Amgen logo
AmgenAMGN
$18.67B+0.2%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$26.25B+90.4%
P/E20.4×+9.3×
P/S8.3×+3.8×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsNetIncludingGoodwill.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's goodwill.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's goodwill?
United Therapeutics (UTHR) reported goodwill of $115.5M in Q1 2026.
How has United Therapeutics's goodwill changed year-over-year?
United Therapeutics's goodwill increased by 3.4% year-over-year, from $111.7M to $115.5M.
What is the long-term trend for United Therapeutics's goodwill?
Over 5 years (2020 to 2025), United Therapeutics's goodwill has grown at a -5.9% compound annual growth rate (CAGR), from $158.1M to $116.5M.
What does goodwill mean?
The excess of acquisition cost over the fair value of net identifiable assets acquired — representing brand value, customer relationships, and synergies from past M&A.